Key points
- Common side effects of THC are tiredness, dizziness, drowsiness, dry mouth and increased appetite. According to the SGCM, they occur mainly at the start and are usually temporary.
- In an analysis of 23 randomised trials, non-serious side effects were more frequent with cannabinoids than with placebo, but serious ones were not. Dizziness was the most common.
- Racing heart, a drop in blood pressure, anxiety and, rarely, psychosis are possible. With regular use, dependence, withdrawal symptoms and recurrent vomiting can occur.
- THC and CBD are advised against during pregnancy and breastfeeding. For chest pain, shortness of breath or confusion, call 144; for questions about an overdose, call 145.
Cannabis medicines can have side effects. Tiredness, dizziness, drowsiness, dry mouth and increased appetite are common. A racing heart, a drop in blood pressure or psychological reactions such as anxiety are also possible. According to the specialist society SGCM, side effects occur mainly at the start of treatment and are usually temporary.1
In clinical trials, adverse effects were more frequent with cannabinoids than with placebo. Most were not serious. Whether a side effect is tolerable is assessed by your doctor case by case: the dose stays the same, is lowered, or the therapy is stopped.1,2,3
Common side effects of cannabis: dizziness, tiredness, dry mouth
The SGCM names as possible side effects of THC mainly tiredness, sedation, drowsiness and dizziness, dry mouth and red eyes, nausea and diarrhoea, headache and increased appetite. For CBD, it names tiredness and sleepiness, reduced appetite and a reversible rise in liver values.1
A large review in the journal JAMA analysed 79 randomised trials with 6462 participants. With cannabinoids, the risk of short-term side effects was higher, including serious ones. Common were dizziness, dry mouth, nausea, tiredness, sleepiness, euphoria, vomiting, disorientation, confusion, balance problems and hallucinations.2
An older review of 23 randomised trials came to a similar picture. Non-serious side effects were around 1.9 times as frequent with cannabinoids as in the comparison groups; for serious side effects there was no clear difference. Dizziness was the most common, at 15.5% of all reported non-serious events. The trials lasted a median of only two weeks and say little about long-term use.3
When other medicines increase side effects
Some side effects become stronger with other products. According to the SGCM, sleeping pills and sedatives, opioids, alcohol and other medicines acting on the nervous system can increase tiredness, sedation and drowsiness. Together with anticholinergics, such as certain medicines for bladder weakness or allergies, dry mouth and dry eyes can increase and the risk of confusion can rise. THC and CBD are broken down in the liver by cytochrome P450 enzymes, so inhibitors or inducers of these enzymes can change the concentration. Which combinations are known is described in the article Interactions with medicines. If you take benzodiazepines, antidepressants or opioids, never stop them abruptly, only in agreement with your doctor.1,11
Concentration and memory
THC can impair attention, reaction time and thinking. The SGCM lists disorders of thinking and speech among the possible side effects. Anyone doing work that requires full concentration should discuss this with their doctor in advance.1,8
Heart and circulation: racing heart and drop in blood pressure
THC can speed up the pulse (tachycardia) and lower blood pressure (hypotension). When standing up quickly, this can lead to dizziness or blacking out. In an overdose, a raised pulse and changes in blood pressure are among the most important physical consequences.1,4
The SGCM therefore requires a strict indication for THC in severe cardiovascular disease, for example coronary heart disease, heart rhythm disorders, angina pectoris or after a heart attack. Together with blood pressure-lowering medicines, blood pressure can drop further, especially at the start. More on this in the article Cannabis and blood pressure medication. Never stop blood pressure-lowering medicines on your own; this can be dangerous.1
Psychological side effects: anxiety and risk of psychosis
THC can change mood. The SGCM names euphoria and dysphoria, that is, elevated or low mood, thought disorders, delusions, psychoses and depression. Acute anxiety and panic attacks are considered the most important psychological consequences of too high a dose.1,4
In severe psychiatric illnesses, especially psychoses and panic attacks, including in the past history, the SGCM requires a strict assessment for THC. What this means for a previous depression or psychosis in the family is explained in the article Cannabis medicine despite a pre-existing mental illness. If you or those around you notice changes in thinking or perception, get in touch promptly.1
Dependence and withdrawal with cannabis
Regular use of cannabis can lead to dependence and a mild withdrawal syndrome. The SGCM considers the risk of developing an addiction extremely low with correct medical use. Nevertheless, for an existing or previous addiction, it requires a strict indication for THC.1,4
The known figures come mainly from recreational use. In an analysis of 21 population studies, 22% of people who used cannabis had a cannabis use disorder. In young people with weekly or daily use, the risk of dependence was 33%. These figures cannot be transferred directly to therapy supervised by a doctor.5
Withdrawal symptoms can occur when regular use is reduced or stopped. In a meta-analysis of 47 studies with 23,518 participants with regular or dependent use, 47% reported withdrawal symptoms; in population samples 17%, in hospital treatment 87%. Daily use was associated with higher rates.6
Cannabinoid hyperemesis syndrome: recurrent vomiting
Cannabinoid hyperemesis syndrome is a rare but distressing consequence of regular cannabis use. It shows itself in recurrent episodes of severe nausea, vomiting and often abdominal pain. In a systematic review, 97.4% of those affected had used cannabis at least weekly. 92.3% compulsively sought hot baths or showers, which relieved the symptoms for a short time.7
In 96.8%, the symptoms subsided when cannabis was no longer used. Because severe vomiting can lead to fluid loss, persistent vomiting requires medical assessment. Do not stop a prescribed therapy on your own in this case, only in agreement with your doctor.7
Fitness to drive, older people and pregnancy
Driving
THC impairs abilities that matter when driving: reaction time, divided attention and keeping in lane. In epidemiological data, the accident risk after smoking cannabis was about twice as high, and impairment was stronger together with alcohol. Anyone who is not fit to drive must not drive, even with a prescription. The rules are described in the article Driving with a prescription.8,1
Older people
According to the SGCM, use in older people is possible and common in practice. Particular attention should be paid to dizziness and drowsiness, as they can lead to falls with serious consequences. With several medicines, interactions should be clarified before starting therapy. In a review of 38 open-label and observational studies of people with a mean age of around 63, serious side effects were rare, but study quality was limited.1,9,11
Pregnancy and breastfeeding
The SGCM advises against THC or CBD during pregnancy and breastfeeding. In a meta-analysis of 24 studies, women who used cannabis during pregnancy more often had anaemia. Their children more often had a low birth weight and more often needed to go to a neonatal intensive care unit. If you are pregnant or would like to become pregnant, talk to your doctor promptly.1,10
What to do about side effects and when to get help
Report mild symptoms such as tiredness or dry mouth at the start to your doctor at the next opportunity. Do not change the dose on your own. Note when the symptom occurred and how long it lasted; this makes assessment easier. Other medicines, alcohol and sleeping pills can increase tiredness and drowsiness.1
According to the SGCM, no lethal doses are known in humans so far. This does not mean that an overdose is harmless: falls, accidents, panic and cardiovascular symptoms can become dangerous.1,12
How it works at evidena
In the medical consultation, the doctor at evidena asks about cardiovascular disease, pre-existing mental illness, addiction, pregnancy and your medicines. The doctor decides whether a cannabis medicine can be considered. A prescription is not guaranteed. If one is issued, it must be filled at a pharmacy within one month. As a rule, the prescribed quantity covers one month, in justified cases at most three months of treatment.13 You can book appointments at https://portal.evidena.care/appointments. Report side effects and questions via WhatsApp or to info@evidena.care. How the therapy works is described on the page Cannabis therapy at evidena.
Conclusion
Most side effects of cannabis medicines are mild and occur at the start. Heart, mind, dependence and recurrent vomiting deserve attention, especially with pre-existing conditions and in older age. Report symptoms to your doctor and get help immediately if there are warning signs.
Frequently asked questions
What are the most common side effects of cannabis?
Studies mainly reported dizziness, dry mouth, nausea, tiredness and sleepiness. According to the SGCM, side effects occur mainly at the start and are usually temporary.
Can you become dependent on medical cannabis?
Yes, dependence is possible with regular use. The SGCM considers the risk extremely low with correct medical use. The higher figures from studies come mainly from recreational use.
What is cannabinoid hyperemesis syndrome?
Recurrent episodes of severe nausea and vomiting with regular cannabis use. Typically, hot showers or baths bring temporary relief. The symptoms usually subside once cannabis is no longer used.
Can I use cannabis during pregnancy?
No. The SGCM advises against THC and CBD during pregnancy and breastfeeding. If you are pregnant or would like to become pregnant, discuss this promptly with your doctor.
When do I need to call the emergency number for side effects?
For chest pain, shortness of breath, fainting, severe confusion or delusions, call 144. For questions about a possible overdose, Tox Info Suisse advises on 145.
Sources
- Allgemeine Informationen zur Anwendung von Medizinalcannabis für Fachpersonen (Fachinformation), Schweizerische Gesellschaft für Cannabis in der Medizin SGCM, ohne Datum (Dateipfad 2024/06), S. 6, 7, 9 und 10 (accessed 11 November 2026)
- Whiting PF et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456-2473. doi:10.1001/jama.2015.6358
- Wang T et al. Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008;178(13):1669-1678. doi:10.1503/cmaj.071178
- Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. doi:10.2165/00003088-200342040-00003
- Leung J et al. What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis. Addict Behav. 2020;109:106479. doi:10.1016/j.addbeh.2020.106479
- Bahji A et al. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(4):e202370. doi:10.1001/jamanetworkopen.2020.2370
- Sorensen CJ et al. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment: a Systematic Review. J Med Toxicol. 2017;13(1):71-87. doi:10.1007/s13181-016-0595-z
- Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013;59(3):478-492. doi:10.1373/clinchem.2012.194381
- Pisani S et al. Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies. Drugs Aging. 2021;38(10):887-910. doi:10.1007/s40266-021-00882-2
- Gunn JK et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986. doi:10.1136/bmjopen-2015-009986
- Lucas CJ et al. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018;84(11):2477-2482. doi:10.1111/bcp.13710
- Tox Info Suisse, Notfallnummer 145 (accessed 11 November 2026)
- Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)